| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bce595c861dba361078ba893e4713be |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-80 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-80 |
| filingDate |
2003-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1efbd3e32b7867b2f2a16d667188683b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22abf72db8e4880740e95c1cb5cb9b18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c0ef7e1acff4ed7cfd25d1540379e9e |
| publicationDate |
2007-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7279500-B2 |
| titleOfInvention |
Sulfonamide cannabinoid agonists and antagonists |
| abstract |
Cannabinoid agonists and antagonists are provided for use in the treatment of disorders such as acute and chronic pain, inflammation, loss of appetite, convulsions, multiple sclerosis, nausea and vomiting. The cannabinoid agonists and antagonists contain a sulfonamide moiety incorporated into the cannabinoid side chain, and the side chain itself may be saturated or unsaturated. |
| priorityDate |
2002-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |